Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Zhang, Yuanyuan, Chen, Hongyan, Mo, Hongnan, Hu, Xueda, Gao, Ranran, Zhao, Yahui, Liu, Baolin, Niu, Lijuan +12 more·2021·Cancer Cell

DOI 10.1016/j.ccell.2021.09.010

Cited by (793)

Items 101–200 of 793

CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer
Y. J. Lee, J. Kim, S. H. Jeon, Heejin Nam, J. Jung, Minwoo Jeon, Eui-Soon Kim, S. Bae, J. Ahn, T. Yoo et al. · 2022 · Science immunology
Defining and using immune archetypes to classify and treat cancer
Alexis J. Combes, Bushra Samad, Matthew F. Krummel · 2023 · Nature reviews. Cancer
Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma
Kui Cao, Jinhong Zhu, Mengdi Lu, Jinfeng Zhang, Yingnan Yang, Xiaodong Ling, Luquan Zhang, Cuicui Qi, Shenshui Wei, Yanqiao Zhang et al. · 2023 · EBioMedicine
Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity
Shijun Ma, Li-Teng Ong, Zemin Jiang, Wee Chyan Lee, Puay Leng Lee, Mubaraka Yusuf, Henrik J. Ditzel, Yulan Wang, Qingfeng Chen, Wenyu Wang et al. · 2024 · Cancer Cell
Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance
Xiaoxia Cheng, Ting Peng, Tian Chu, Yiqun Yang, Jia Liu, Qinglei Gao, Canhui Cao, Juncheng Wei · 2025 · Journal of Hematology & Oncology
Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer
Bing Lu, Ru Qiu, Jiatian Wei, Li Wang, Qinkai Zhang, Mingsen Li, Xiudan Zhan, Jian Chen, I-Yun Hsieh, Ciqiu Yang et al. · 2024 · Nature Cancer
Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer
Meriem Belabed, Matthew D. Park, Cédric M. Blouin, Sreekumar Balan, Chang Yoon Moon, Grace S. Freed, Miguel Quijada‐Álamo, Ante Peros, Raphaël Mattiuz, Amanda M. Reid et al. · 2025 · Nature Immunology
Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response
Qiu, Miao-Zhen, Wang, Chaoye, Wu, Zhiying, Zhao, Qi, Zhao, Zhibin, Huang, Chun-Yu, Wu, Wenwei, Yang, Li-Qiong, Zhou, Zhi-Wei, Zheng, Yu et al. · 2023 · Signal Transduction and Targeted Therapy
Exploring the Impact of TREM2 in Tumor-Associated Macrophages
Darya Khantakova, Simone Brioschi, Martina Molgora · 2022 · Vaccines
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy
Myriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, Christophe Borg, Olivier Adotévi, Romain Loyon · 2022 · Cancers
Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity
Minjie Pan, Xiao‐Shan Wei, Xuan Xiang, Yanhong Liu, Qiong Zhou, Wei-Bing Yang · 2023 · Clinical & Translational Oncology
Single-cell immune repertoire analysis
Sergio Erdal Irac, Megan S. F. Soon, Nicholas C. Borcherding, Zewen Kelvin Tuong · 2024 · Nature Methods
Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance
Xuan Zou, Xuan Lin, He Cheng, Yusheng Chen, Ruijie Wang, Mingjian Ma, Yu Liu, Zhengjie Dai, Yesboli Tasiheng, Yu Yan et al. · 2023 · Journal for ImmunoTherapy of Cancer
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results
Peter Schmid, Nicholas C. Turner, Carlos H. Barrios, Steven Jay Isakoff, Sung‐Bae Kim, Marie‐Paule Sablin, Shigehira Saji, Peter Stephen Savas, Gregory A. Vidal, Mafalda Oliveira et al. · 2023 · Clinical Cancer Research
New horizons at the interface of artificial intelligence and translational cancer research
Josephine Yates, Eliezer M. Van Allen · 2025 · Cancer Cell
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma
Jia‐Cheng Lu, Lei‐Lei Wu, Yining Sun, Xiaoyong Huang, Chao Gao, Xiao-Jun Guo, Haiying Zeng, Xu-Dong Qu, Yi Chen, Dong Wu et al. · 2024 · Nature Communications
Technology meets TILs: Deciphering T cell function in the -omics era
William H. Hudson, Andreas Wieland · 2022 · Cancer Cell
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
Minae An, Arnav Mehta, Byung‐Hoon Min, You Jeong Heo, Samuel J. Wright, Milan Parikh, Lynn Bi, Hyuk Lee, Tae Jun Kim, Song-Yi Lee et al. · 2024 · Cancer Discovery
Liposomes-enabled cancer chemoimmunotherapy
Lele Zhang, Jiangpei Shi, Mao‐Hua Zhu, Yanhu Huang, Qin Lu, Peng Sun, Hongzhuan Chen, Xing Ping Lai, Chao Fang · 2024 · Biomaterials
Single-cell transcriptomics reveals intratumor heterogeneity and the potential roles of cancer stem cells and myCAFs in colorectal cancer liver metastasis and recurrence
Zhan Yao, Dong Sun, Jie Gao, Qinglun Gao, Yanfeng Lv, Tiantian Du, Yaqi Dong, Yunshan Wang, Hanxiang Zhan, Juan Li et al. · 2025 · Cancer Letters
An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer
Kaiyi Li, Chang Liu, Xizhao Sui, Chao Li, Ting Zhang, Tian Zhao, Dong Zhang, Hainan Wu, Yuhan Liu, Shuai Wang et al. · 2025 · Cell stem cell
Liquid Metal Nanoplatform Based Autologous Cancer Vaccines
Dawei Wang, Zhongyang Yu, Yuxia Qi, Kaiwen Hu, Tian Gang Zhou, Jing Liu, Wei Rao · 2023 · ACS Nano
The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating
Yize Mao, Hui Xie, Min‐Yi Lv, Qiuxia Yang, Zeyu Shuang, Feng Gao, Shengping Li, Lina Zhu, Wei Wang · 2023 · Cancer Immunology Immunotherapy
Low-avidity T cells drive endogenous tumor immunity in mice and humans
Summit Singhaviranon, Joseph P. Dempsey, Adam T. Hagymasi, Ion Măndoiu, Pramod Kumar Srivastava · 2025 · Nature Immunology
Emerging clinical applications of single-cell RNA sequencing in oncology
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, Noam Galili Darnell, Alissa Greenwald, Rouven Hoefflin, Daniel Kovarsky, Dor Simkin, Shira Turgeman, Lingling Zhang et al. · 2025 · Nature Reviews Clinical Oncology
CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer
Song‐Yang Wu, Si-Wei Zhang, Ding Ma, Yi Qun Xiao, Yin Liu, Li Chen, Xiao-Qing Song, Xiao-Yan Ma, Ying Xu, Wen-Jun Chai et al. · 2023 · Med
Novel insights into paclitaxel’s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment
Yoonjeong Choi, Seong A Kim, Hanul Jung, Yoon Kyoung Kim, Seohyun Kim, Jaehyun Kim, Jaehyun Kim, Yeji Lee, Min Kyoung Jo, Jiwan Woo et al. · 2024 · Journal for ImmunoTherapy of Cancer
Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development
Yuma Takano, Jun Suzuki, Kotaro Nomura, Gento Fujii, Junko Zenkoh, Hitomi Kawai, Yuta Kuze, Yukie Kashima, Satoi Nagasawa, Yuka Nakamura et al. · 2024 · Nature Communications
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial
Songyang Wu, Xi Jin, Yin Liu, Zi-Yu Wang, Wen‐Jia Zuo, Ding Ma, Yi Xiao, Tong Fu, Yu-Ling Xiao, Li Chen et al. · 2025 · Nature Medicine
Nanomedicine-mediated regulated cell death in cancer immunotherapy
Yue Ling Sun, Ting Lian, Qichao Huang, Yawei Chang, Yuan Li, Xiaoyu Guo, Weirong Kong, Yi‐Fang Yang, Kun Zhang, Pan Wang et al. · 2023 · Journal of Controlled Release
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics
Wendi Liu, Anusha Puri, Doris Fu, Lee Chen, Cassia Wang, M Kellis, Jiekun Yang · 2023 · Clinical & Experimental Metastasis
Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment
Faezzah Baharom, Dalton Hermans, Lélia Delamarre, Robert A. Seder · 2024 · Nature reviews. Immunology
Dual Immune Checkpoint Blockade Induces Analogous Alterations in the Dysfunctional CD8+ T-cell and Activated Treg Compartment
Anne M. van der Leun, Joleen J.H. Traets, Joris L. Vos, Joris B.W. Elbers, Sanne Patiwael, Xiaohang Qiao, Mercedes Machuca-Ostos, Daniela S. Thommen, John B.A.G. Haanen, Ton N. Schumacher et al. · 2023 · Cancer Discovery
Intratumoral CD103 + CD8 + T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma
Siqi Ren, Tianjun Lan, Fan Wu, Suling Chen, Xue Jiang, Chuying Huo, Zitian Li, Shule Xie, Donghui Wu, Ruixin Wang et al. · 2023 · 癌症：英文版
Immunotherapy in breast cancer: current landscape and emerging trends
Ran Ran, Xi Chen, Jin Yang, Binghe Xu · 2025 · Experimental Hematology and Oncology
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation
Laurent Gorvel, Daniel Olive · 2022 · Seminars in Immunology
An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS -Mutant Intrahepatic Cholangiocarcinoma
Mao Zhang, Yingying Huang, Jiaomeng Pan, Chen Sang, Youpei Lin, Liangqing Dong, Xia Shen, Yingcheng Charles Wu, Guohe Song, Shuyi Ji et al. · 2023 · Cancer Discovery
Immunogenomic cancer evolution: A framework to understand cancer immunosuppression
Shogo Kumagai, Yusaku Momoi, Hiroyoshi Nishikawa · 2025 · Science Immunology
Intratumoral immunotherapy relies on B and T cell collaboration
Idit Sagiv-Barfi, Debra Katherine Czerwinski, Tanaya Shree, Julian J.K. Lohmeyer, Ronald Levy · 2022 · Science Immunology
Application of single-cell sequencing to the research of tumor microenvironment
Sijie Chen, Zhiqing Zhou, Yu Li, Yuhui Du, Guoan Chen · 2023 · Frontiers in Immunology
Cancer Immunotherapy Based on the Bidirectional Reprogramming of the Tumor Microenvironment by a “Brakes Off/ Step on the Accelerator” Core‐Shell Manganese Phosphate/siPD‐L1 Modulator
Fei Xia, Yuqian Lu, Zipeng Gong, Qingchao Tu, Shuntao Liang, Chen Wang, HaiLu Yao, Lin Zhong, Yuanfeng Fu, Pengbo Guo et al. · 2025 · Exploration
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
Ronan Flippot, Marcus Teixeira, Macarena Rey-Cárdenas, Lucía Carril-Ajuria, Larissa Rainho, Natacha Naoun, Jean-Mehdi Jouniaux, Lisa Boselli, Marie Naigeon, François‐Xavier Danlos et al. · 2024 · Journal for ImmunoTherapy of Cancer
Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer
Xiaohuan Tang, Mengyuan Li, Xiaolong Wu, Ting Guo, Li Zhang, Lei Tang, Fangzhou Jia, Ying Hu, Yan Zhang, Xiaofang Xing et al. · 2022 · OncoImmunology
Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer
Álvaro Marcos Rubio, Celine Everaert, Eufra Van Damme, Katleen De Preter, Karim Y. Vermaelen · 2023 · Journal for ImmunoTherapy of Cancer
Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma
Hidekazu Oyoshi, Junyan Du, Shunsuke A. Sakai, Riu Yamashita, Masayuki Okumura, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Hidenari Hirata, Hironori Sunakawa et al. · 2023 · Science Advances
Current Perspectives on Paclitaxel: Focus on Its Production, Delivery and Combination Therapy
Yibin Liu, Feng-Lan Zhao, Qibao Wang, Qingjie Zhao, Gui‐Ge Hou, Qingguo Meng · 2023 · Mini-Reviews in Medicinal Chemistry
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond
Can Cui, Joseph E. Craft, Nikhil S. Joshi · 2023 · Seminars in Immunology
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Michael D. Iglesia, Reyka G. Jayasinghe, Siqi Chen, Nadezhda V. Terekhanova, John M. Herndon, Erik P. Storrs, Alla Y. Karpova, Daniel Cui Zhou, Nataly Naser Al Deen, Andrew T. Shinkle et al. · 2024 · Nature Cancer
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer
Hanwen Wang, Chen Zhao, Cesar Augusto Santa-Maria, Leisha A. Emens, Aleksander S. Popel · 2022 · iScience
Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer
Wenxin Wu, Ming Xu, Bin Qiao, Tongyi Huang, Huanling Guo, Nan Zhang, Luyao Zhou, Manying Li, Tan Yang, Minru Zhang et al. · 2022 · Acta Biomaterialia
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
Lestat R. Ali, A. Garrido-Castro, P. Lenehan, Naima Bollenrucher, Courtney T. Stump, M. Dougan, S. Goel, G. Shapiro, S. Tolaney, S. Dougan · 2023 · Journal of Experimental Medicine
New insights into the role of macrophages in cancer immunotherapy
Zhou Li, Tiantian Zhao, Ruzhe Zhang, Chen Chen, Jiwei Li · 2024 · Frontiers in Immunology
Single-cell and spatial transcriptomics integration: new frontiers in tumor microenvironment and cellular communication
Wenxin Shi, Zhiqiang Zhang, Xiaotong Xu, Yanpeng Tian, Li Feng, Xianghua Huang, Yanfang Du, Zhongkang Li · 2025 · Frontiers in Immunology
Dynamic CD8+ T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy
Anaïs Vermare, Marion V. Guérin, Elisa Peranzoni, Nadège Bercovici · 2022 · Cancers
Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
Jing Wen, Shuogui Fang, Yi Hu, Mian Xi, Zelin Weng, Chuqing Pan, Kongjia Luo, Yihong Ling, Renchun Lai, Xiuying Xie et al. · 2022 · EBioMedicine
Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters
Dawoon Han, Ayeong Lee, Taehee Kim, Ji Young Choi, Mi Yeon Cho, Ahreum Song, Chang-Hyeon Kim, Joonho Shim, Hyun Je Kim, Honesty Kim et al. · 2023 · Journal of Clinical Investigation
Spatial determinants of CD8+ T cell differentiation in cancer
Katherine Tooley, Giulia Escobar, Ana Carrizosa Anderson · 2022 · Trends in cancer
Engineering the Intestinal Lymphatic Transport of Oral Nanoparticles to Educate Macrophages for Cancer Combined Immunotherapy
Lu Xu, Shufeng Weng, Shengqi Li, Ke Wang, Yu Shen, Ying Xu, Cui Tang, Chunhua Yin · 2023 · ACS Nano
Stem-like progenitor and terminally differentiated TFH-like CD4+ T cell exhaustion in the tumor microenvironment
Wenhao Zhou, Shusuke Kawashima, Takamasa Ishino, Katsushige Kawase, Youki Ueda, Kazuo Yamashita, Tomofumi Watanabe, Masahito Kawazu, Hiromichi Dansako, Yutaka Suzuki et al. · 2024 · Cell Reports
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
Hongnan Mo, Yongpei Yu, Xiaoying Sun, Hewei Ge, Lanlan Yu, Xiuwen Guan, Jingtong Zhai, Aihua Zhu, Yuhan Wei, Jinjing Wang et al. · 2024 · Nature Medicine
Multi-omics in immunotherapy research for HNSCC: present situation and future perspectives
Xuan-Hao Liu, Guang-Rui Wang, Nian‐Nian Zhong, Weiyu Wang, Bing Liu, Zhizhong Li, Lin‐Lin Bu · 2025 · npj Precision Oncology
Efficacy, safety and single-cell analysis of neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma: a phase II trial
Zhongzheng Xiang, Xiaoyuan Wei, Zhuoyuan Zhang, Yueyang Tang, Linyan Chen, Chen-feng Tan, Yuanyuan Zeng, Jun Wang, Guile Zhao, Zelei Dai et al. · 2025 · Nature Communications
Integrative mapping of human CD8+ T cells in inflammation and cancer
Ziwei Xue, Lize Wu, Ruonan Tian, Bing Xin Gao, Yu Shan Zhao, Bing He, Di Sun, Bin Zhao, Yicheng Li, Kaixiang Zhu et al. · 2024 · Nature Methods
Update on triple‐negative breast cancers – highlighting subtyping update and treatment implication
Julia Y. Tsang, Gary Man-Kit Tse · 2022 · Histopathology
Deep learning identifies a T-cell exhaustion-dependent transcriptional signature for predicting clinical outcomes and response to immune checkpoint blockade
Zicheng Zhang, Hongyan Chen, Dongxue Yan, Lu Chen, Jie Sun, Meng Zhou · 2023 · Oncogenesis
High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy
Dingpei Han, Yichao Han, Wei Guo, Wei Wei, Su Yang, Jie Xiang, Jiaming Che, Lianggang Zhu, Junbiao Hang, Tom van den Ende et al. · 2023 · Journal for ImmunoTherapy of Cancer
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Dian Xiong, Lu Zhang, Zhi‐Jun Sun · 2023 · Military Medical Research
PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages
Michael Reginald Pitter, Ilona Kryczek, Hongjuan Zhang, Nisha Nagarsheth, Houjun Xia, Zhenyu Wu, Yuzi Tian, Karolina Okła, Peng Liao, Weichao Wang et al. · 2024 · Cell Reports
Multiome in the Same Cell Reveals the Impact of Osmotic Stress on Arabidopsis Root Tip Development at Single‐Cell Level
Qing Liu, Wei Ma, Ruiying Chen, Shang‐Tong Li, Qifan Wang, Cai Wei, Yiguo Hong, Hai‐Xi Sun, Qi Cheng, Jianjun Zhao et al. · 2024 · Advanced Science
IL-1β+ macrophages and the control of pathogenic inflammation in cancer
Nicoletta Caronni, Federica La Terza, Luca Frosio, Renato Ostuni · 2025 · Trends in Immunology
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer
Eleonora Ghisoni, Fabrizio Benedetti, Aspram Minasyan, Mathieu Desbuisson, Paula Cunnea, Alizée J Grimm, Noémie Fahr, Charlotte Capt, Nicolas Rayroux, Flavia De Carlo et al. · 2025 · Cancer Cell
HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer.
Yi Xiao, Ying Xu, Han Wang, Fan Yang, Xiao-Hong Ding, Tong Fu, Li Chen, Xi Jin, Ya-Xin Zhao, Ying Wang et al. · 2025 · Cell Metabolism
HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration
Bicheng Ying, Wenting Xu, Yan Guang Nie, Yongtao Li · 2022 · Disease Markers
Metabolism in tumor-associated macrophages
Jie Li, Gina M. DeNicola, Brian Ruffell · 2022 · International review of cytology
Lymphatic system regulation of anti-cancer immunity and metastasis
Pin‐Ji Lei, Cameron S. Fraser, Dennis Jones, Jessalyn M. Ubellacker, Timothy P. Padera · 2024 · Frontiers in Immunology
Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results
Niu Liu, Jiaying Wu, Enze Deng, Jianglong Zhong, Bin Wei, Tingting Cai, Zhijun Xie, Xiaohui Duan, Sha Fu, David O. Osei-Hwedieh et al. · 2025 · Nature Medicine
Relationships of tumor differentiation and immune infiltration in gastric cancers revealed by single-cell RNA-seq analyses
Xin Zhou, Jingwei Yang, Yongqu Lu, Yanpeng Ma, Yan Meng, Qingqing Li, Junpeng Gao, Zhaoyu Jiang, Limei Guo, Wei Wang et al. · 2023 · Cellular and Molecular Life Sciences
Personalized tumor combination therapy optimization using the single-cell transcriptome
Chen Tang, Shaliu Fu, Xuan Jin, Wannian Li, Feiyang Xing, Bin Duan, Xiaojie Cheng, Xiaohan Chen, Shuguang Wang, Chenyu Zhu et al. · 2023 · Genome Medicine
B Cells in Breast Cancer Pathology
Mengyuan Li, Ángela Quintana, Elena Alberts, Miu Shing Hung, Victoire Boulat, Mercè Martı́, Anita E. Grigoriadis · 2023 · Cancers
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Stéphane Fattori, Aude Le Roy, Jemila Houacine, Lucie Robert, Riad Abès, Laurent Gorvel, Samuel Granjeaud, Marie-Sarah Rouviére, Amira Ben Amara, Nicolas Boucherit et al. · 2023 · Cancer Research
The tumor microenvironment and triple-negative breast cancer aggressiveness: Shedding light on mechanisms and targeting
Natsuki Furukawa, V. Stearns, C. Santa-Maria, A. Popel · 2022 · Expert opinion on therapeutic targets
Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways
Junyan Du, Shun‐Ichiro Kageyama, Riu Yamashita, Kosuke Tanaka, Masayuki Okumura, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Hidenari Hirata, Hironori Sunakawa et al. · 2023 · Communications Biology
Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
Andrea Ziblat, Brendan L. Horton, Emily F. Higgs, Ken Hatogai, Anna Martinez, Jason W. Shapiro, Danny EC Kim, Yuanyuan Zha, Randy F. Sweis, Thomas Frank Gajewski · 2024 · Cell Reports
Unlocking T cell exhaustion: Insights and implications for CAR-T cell therapy
Dian Xiong, Haijun Yu, Zhi‐Jun Sun · 2024 · Acta Pharmaceutica Sinica B
The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy
Ana Rita Salgado Ribeiro, Theresa Neuper, Jutta Horejs‐Hoeck · 2024 · International Journal of Nanomedicine
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents
Jitka Palich Fucikova, Lenka Palová-Jelínková, Vanessa Klapp, Peter Holíček, Tereza Láníčková, Lenka Kašíková, Jana Drozenová, David Cibula, Beatriz Álvarez-Abril, Elena García-Martínez et al. · 2022 · Trends in cancer
The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases
Mariana Reste, Kristi Ajazi, Ayca Sayi‐Yazgan, Radmila Janković, Biljana Bufan, Sven Brandau, Espen S. Bækkevold, Florent Petitprez, Malin Lindstedt, Gosse J. Adema et al. · 2024 · Frontiers in Immunology
Regulation of T cell exhaustion and stemness: molecular mechanisms and implications for cancer immunotherapy
Zeyu Chen, Ziang Zhu, Taidou Hu, Chen Yao, Tuoqi Wu · 2025 · Cellular and Molecular Immunology
A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies
Laura Carpen, Paolo Falvo, S. Orecchioni, G. Mitola, R. Hillje, S. Mazzara, P. Mancuso, S. Pileri, A. Raveane, F. Bertolini · 2021 · Cell Death Discovery
Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance
Hyungjoo Kim, Je‐Min Choi, Kyung‐min Lee · 2022 · Biomedicines
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
O. Barboy, A. Bercovich, Han-Jie Li, Y. Eyal-Lubling, Adam Yalin, Yuval Shapir Itai, Kathleen Abadie, M. Zada, Eyal David, Shir Shlomi-Loubaton et al. · 2024 · Nature Cancer
Modulating and Imaging Macrophage Reprogramming for Cancer Immunotherapy
Jialu Wang, Yafang Lu, Ren Zhang, Zhenzhen Cai, Zhan Ming Fan, Yilun Xu, Zheng Liu, Zhihong Zhang · 2024 · Phenomics
Present and Future of Immunotherapy for Triple-Negative Breast Cancer
Sushmitha Sriramulu, Shivani Thoidingjam, Corey Wayne Speers, Shyam Nyati · 2024 · Cancers
YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer
Hao Jin, Yue Chen, Dongbo Zhang, Junfan Lin, Songyin Huang, Xiaohua Wu, Wen Deng, Jiandong Huang, Yandan Yao · 2024 · iScience
C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancer
Xi Li, Alfonso Poire, Kang Jin Jeong, Dong Zhang, Tugba Y. Ozmen, Gang Chen, Chaoyang Sun, Gordon Brent Mills · 2024 · Nature Communications
Silencing of COL3A1 represses proliferation, migration, invasion, and immune escape of triple negative breast cancer cells via down‐regulating PD‐L1 expression
Fan Yang, Ling Lin, Xiaohua Li, Ronglan Wen, Xin Zhang · 2022 · Cell Biology International
Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing
Yingtai Chen, Jianhua Yin, Lulu Zhao, Guangyu Zhou, Shichen Dong, Yueming Zhang, Penghui Niu, Hu Ren, Tianjiao Zheng, Juan Yan et al. · 2022 · Journal of Translational Medicine
Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors
Lizhong Ding, Lu Sun, Melissa Tian Bu, Yanjun Zhang, Lauren N Scott, Robert Michael Prins, Maureen A. Su, Melissa G. Lechner, Willy Hugo · 2023 · Frontiers in Immunology
Tryptophan metabolism regulates inflammatory macrophage polarization as a predictive factor for breast cancer immunotherapy.
Linxuan Xue, Chao Wang, Yu-Lu Qian, Wenqiang Zhu, Lina Liu, Xiao-Hong Yang, Shuhua Zhang, Da-Ya Luo · 2023 · International Immunopharmacology
Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer
Jindong Xie, Wenjian Liu, Xinpei Deng, Huan Wang, Xueqi Ou, Xin An, Minyi Situ, Anli Yang, Chuan Peng, Rongfang He et al. · 2025 · Advanced Science